{"id":240816,"date":"2026-07-14T09:14:29","date_gmt":"2026-07-14T14:14:29","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/new-cancer-drug-shows-promise-in-mesothelioma-trial"},"modified":"2026-07-14T09:14:29","modified_gmt":"2026-07-14T14:14:29","slug":"new-cancer-drug-shows-promise-in-mesothelioma-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/new-cancer-drug-shows-promise-in-mesothelioma-trial","title":{"rendered":"New cancer drug shows promise in mesothelioma trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-cancer-drug-shows-promise-in-mesothelioma-trial2.jpg\"><\/a><\/p>\n<p>Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year.<\/p>\n<p>Current treatments\u2014immunotherapy and chemotherapy\u2014offer limited benefit. Patients\u2014often men who worked in shipbuilding, oil refining and asbestos manufacturing\u2014face a median survival of approximately 12 months and a five-year survival rate of around 10%.<\/p>\n<p>\u201cIt\u2019s a disease of a significant unmet medical need,\u201d says Brian Cunniff, a professor at the University of Vermont.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mesothelioma is a rare but aggressive cancer, usually caused by exposure to asbestos. Inhaled asbestos fibers become lodged in the lungs, causing inflammation that can lead to tumor formation decades later. Worldwide, about 30,000 people are diagnosed with mesothelioma each year. Current treatments\u2014immunotherapy and chemotherapy\u2014offer limited benefit. Patients\u2014often men who worked in shipbuilding, oil refining [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-240816","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=240816"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240816\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=240816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=240816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=240816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}